Syndrome News and Research

RSS

Cannabinoids hold promise in treating children with epilepsy

In recent years, cannabinoids--the active chemicals in medical marijuana-- have been increasingly touted as a potential treatment for a range of neurological and psychiatric disorders. In a Developmental Medicine & Child Neurology review, investigators compare their efficacy with antiepileptic drugs for children with epilepsy.

7 Nov 2018

New study highlights need for psychological screening for carers of child burn victims

A new study published in the Journal of Pediatric Psychology highlights the need for psychological screening for families/primary caregivers after a child sustains a burn injury.

6 Nov 2018

Energy drinks narrow blood vessels within 90 minutes of intake

Researchers have found that within one and half hour of taking an energy drink the internal diameter of the blood vessels is reduced by half on an average. As the blood vessels narrow, the vital blood supply to the organs also reduces and this can lead to several problems – heart attacks and strokes being just two of them.

5 Nov 2018

Researchers develop computer game to help prevent thrombosis

A clot in a blood vessel can block the artery. This is what doctors call thrombosis. To prevent thrombosis, exercises for legs and feet help. Often, however, those affected lack motivation. The computer game "jumpBALL", developed by Kaiserslautern researchers together with medical doctors, provides helpful support.

5 Nov 2018

Scientists figure out way to measure fetal cardiac electrical activity

Electrodes are placed on the patient's chest area to record cardiac electrical activity - e.g. to determine whether the heart rhythm is so irregular that treatment is required; a type of medical examination for which ECG serves well as a diagnostic tool.

2 Nov 2018

Researchers for first time view serotonin activating its receptor using high-powered microscopes

Serotonin receptors are common drug targets in the treatment of pain, gastrointestinal dysfunctions, and mood disorders yet little is known about their three-dimensional structure.

2 Nov 2018

Rubella eliminated from Australia confirms WHO

The World Health Organization (WHO) has confirmed that Australia has managed to eliminate the viral infection rubella from its population. This is a significant achievement on part of the country’s healthcare system. WHO defines elimination of a disease as “reduction to zero of the incidence of infection caused by a specific agent in a defined geographical area”.

2 Nov 2018

Inflammation can cause sleep and shiftwork-type disorders

Inflammation, which is the root cause of autoimmune disorders including arthritis, Type 1 diabetes, irritable bowel syndrome and Crohn's disease, has unexpected effects on body clock function and can lead to sleep and shiftwork-type disorders, a new Northwestern Medicine study in mice found.

31 Oct 2018

Scientists identify 'skeleton key' for congenital kidney disease research

Scientists in Japan have found a 'skeleton key' for congenital kidney disease research. Using iPS cells generated from the skin cells of a patient with a nephrin mutation, Kumamoto University scientists have successfully developed kidney tissue that exhibits the early stages of congenital kidney disease.

31 Oct 2018

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of immunotherapy in oncology. An international team’s work has shed new light on a molecule called TIM-3 that might play a key role in the regulation of the immune response.

31 Oct 2018

Using genome editing to prevent sudden cardiac death

Each year, at least 3 million people worldwide die of sudden cardiac death. In the U.S., this number reaches up to 450,000 people.

30 Oct 2018

Study finds increase in opioid-affected births to rural residents in rural and urban hospitals

The opioid epidemic has had devastating effects on families in rural communities, places where both maternity care and substance use treatment are limited.

30 Oct 2018

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

Neuroene Therapeutics, a start-up company founded by mitochondrial biologist Sherine S. L. Chan, Ph.D. and medicinal chemist C. James Chou, Ph.D. of the Medical University of South Carolina, has received a $1.5 million NIH Phase II Small Business Innovation Research grant to optimize vitamin K analogues that could improve seizure control in patients with drug-resistant epilepsy.

29 Oct 2018

Forced expression of a natural protein reduces fat in mice by a third

In a mouse model of obesity, forced expression of the protein FGFBP3 (BP3 for short) significantly reduced the animals’ fat mass.

29 Oct 2018

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

To the great surprise of cancer researchers, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

29 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Stroke specialists often see conditions known as stroke "mimics" and "chameleons" that can complicate accurate diagnoses, Loyola Medicine neurologists report in the November 2018 issue of Neuroimaging Clinics of North America.

26 Oct 2018

Quadrant Biosciences announces collaboration on research into treatment of ASD

Quadrant Biosciences, Inc., an emerging life science company based in Syracuse, N.Y., today announced its collaboration with the Autism Speaks® Autism Treatment Network and its university research partners on research into the treatment of autism spectrum disorder.

26 Oct 2018

Researchers track where tetracycline antibiotics go in human cells

We know that antibiotics treat bacterial infections. We also know why they work. Tetracycline antibiotics, for example, stop bacteria from making protein. Like a boot on a wheel, the drugs bind to the bacterial cell's ribosome--where protein is made--and prevent it from working. Without protein, the bacteria weaken and die.

25 Oct 2018

Loss of serotonin neuron activity blunts the body’s ability to recover from interrupted breathing

Scientists trying to identify the roots of sudden infant death syndrome, the leading cause of death in U.S. infants between 1 month and 1 year old, have increasingly turned their attention to the neurotransmitter serotonin and the brain cells that produce it.

25 Oct 2018

Syndrome News and Research

Cannabinoids hold promise in treating children with epilepsy

New study highlights need for psychological screening for carers of child burn victims

Energy drinks narrow blood vessels within 90 minutes of intake

Researchers develop computer game to help prevent thrombosis

Scientists figure out way to measure fetal cardiac electrical activity

Researchers for first time view serotonin activating its receptor using high-powered microscopes

Rubella eliminated from Australia confirms WHO

Inflammation can cause sleep and shiftwork-type disorders

Scientists identify 'skeleton key' for congenital kidney disease research

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Using genome editing to prevent sudden cardiac death

Study finds increase in opioid-affected births to rural residents in rural and urban hospitals

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

Forced expression of a natural protein reduces fat in mice by a third

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Quadrant Biosciences announces collaboration on research into treatment of ASD

Researchers track where tetracycline antibiotics go in human cells

Loss of serotonin neuron activity blunts the body’s ability to recover from interrupted breathing

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News